Navigation Links
Hothead Technologies Partners with Shafer Enterprises to Provide Break-Through Technology to Monitor and Manage Normothermia in Medical Patients
Date:5/11/2010

medical equipment. The SafeTemp (normothermia monitoring and management system) is currently in prototype stage and will go through further research and testing over the next several months.

The SafeTemp unit can be used for all your temperature monitoring applications throughout a medical facility from ambulatory to ICU.

About Hothead Technologies, Inc.

Hothead Technologies, Inc., is an Atlanta-based company offering a patent-pending and proprietary monitoring solution termed the Heat Observation Technology (H.O.T.™) system. The system is designed as an aid in the prevention of heat-related illness in athletes, firefighters, military personnel, industrial, medical and hazmat professionals. Heat Observation Technology (H.O.T.™) and the Hothead Technologies® logo are trademarks of Hothead Technologies, Inc. For more information visit www.hotheadtechnologies.com.

About Shafer Enterprises, LLC

Since 1987, Shafer Enterprises' Cool Shirt® has been the world leader in personal temperature regulation systems. Our mission is to create innovative products that help people manage body temperature in extreme environments. Body temperature related illnesses and deaths are preventable and we believe our products help in that prevention. After more than 20 years experience in the medical field and extensive research on cooling the human body, we have developed systems specifically for surgeons, racecar drivers, football players, firefighters, emergency services/hazmat workers, industrial applications and now medical p
'/>"/>

SOURCE Hothead Technologies, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. OrthoAccel Technologies, Inc. and AB Orthodontics Announce Partnership and Australian Product Introduction
2. BioSpecifics Technologies Corp. to Host Conference Call to Report First Quarter 2010 Financial Results on May 7, 2010
3. Wireless-Life Sciences Alliance (WLSA) Applauds Partner Organizations for Supporting Goal of Improving Healthcare Via Wireless Technologies
4. Althea Technologies Acquires Altus Pharmaceuticals(R) Assets and IP Portfolio, Establishing Technology Platform for Protein Formulations.
5. China Medical Technologies to Announce Results for the Fourth Fiscal Quarter and the Fiscal Year Ended March 31, 2010 on June 4, 2010
6. China Medical Technologies to Participate in Investor Conferences in May and June 2010
7. CareFusion, Cerner to Integrate Technologies for Improved Hospital Safety, Efficiency
8. Lakeside Behavioral Healthcare Named Winner of First Annual Netsmart Technologies Customer Innovation Award
9. MultiCell Technologies Is Granted European Patent for the Treatment of Cancer
10. MicroMass Named Agency of Record for North Carolina Advanced Medical Technologies Center of Innovation
11. Palatin Technologies, Inc. Receives $2.5 Million from AstraZeneca
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)... LEXINGTON, Mass. , Feb. 27, 2015   ... GEVA ), a biopharmaceutical company developing therapeutic products ... Rare Disorders™ (NORD™), the European Organisation for Rare ... around the world in observing Rare Disease Day. ... each year, patient organizations, industry, and other participants ...
(Date:2/27/2015)... 2015  PTC Therapeutics, Inc. (NASDAQ: PTCT ... results for the fourth quarter and full year ended ... transformative year for PTC. We are now a growing ... therapies in the rare disease space," stated Stuart W. ... are proud to bring the first treatment for Duchenne ...
(Date:2/27/2015)... , Feb. 27, 2015  Uroplasty, Inc. (NASDAQ: ... and markets innovative proprietary products to treat voiding dysfunctions, ... Annual ROTH Conference on Tuesday, March 10, 2015. ... Reynolds , Chief Financial Officer, will present at 4:00 ... one at the conference at the Ritz Carlton in ...
Breaking Medicine Technology:Synageva BioPharma Joins NORD, EURORDIS, And The Global Genes Project In Support Of Rare Disease Day 2015 2Synageva BioPharma Joins NORD, EURORDIS, And The Global Genes Project In Support Of Rare Disease Day 2015 3Synageva BioPharma Joins NORD, EURORDIS, And The Global Genes Project In Support Of Rare Disease Day 2015 4Synageva BioPharma Joins NORD, EURORDIS, And The Global Genes Project In Support Of Rare Disease Day 2015 5Synageva BioPharma Joins NORD, EURORDIS, And The Global Genes Project In Support Of Rare Disease Day 2015 6PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 2PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 3PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 4PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 5PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 6PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 7PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 8PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 9PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 10PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 11Uroplasty to Participate in the 27th Annual ROTH Conference 2
... 15 VION,PHARMACEUTICALS, INC. (Nasdaq: VION ) today ... to the pivotal Phase II trial of its lead ... novo poor-risk acute myelogenous leukemia (AML). Alan Kessman, ... reached this milestone in the pivotal Phase II trial ...
... Study to Explore the Efficacy of Novel Proteasome Inhibitor ... Patients with Relapsed and Refractory Multiple Myeloma, SOUTH ... Multiple Myeloma Research Consortium (MMRC) and Proteolix, Inc. today,announced ... Phase 2,clinical trial to study Proteolix,s potent and selective ...
Cached Medicine Technology:Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML 2Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML 3Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML 4The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma 2The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma 3The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma 4
(Date:2/28/2015)... February 28, 2015 For those people ... person, the Mesothelioma Applied Research Foundation (Meso ... Tuesday, March 3, starting at 9:30 AM. , The ... registration. The broadcast can be accessed through any browser ... . , The Symposium is a unique event that ...
(Date:2/28/2015)... Orlando, FL (PRWEB) February 28, 2015 ... community organization has sponsored visitor health insurance programs for ... 25 years. Most Indian elderly parents traveling to the ... conditions such as diabetes and blood pressure. These diseases ... do not even list them as medical conditions. There ...
(Date:2/28/2015)... 2015 The noted Friedman Dental Group ... have officially relaunched their website. The new version of ... contains a new section about their team members. Potential ... full biographies of each Friedman Dental Group team member ... was designed to provide our patients with the opportunity ...
(Date:2/28/2015)... 28, 2015 Plugin creators from Pixel ... 2. A fully customizable transition pack made ... 2 gives users total control over 30 transition presets ... of Pixel Film Studios. “TransFold Volume 2 gives endless ... TransFold Volume 2 from Pixel Film Studios brings back ...
(Date:2/27/2015)... Hispanics develop alcoholic liver disease (ALD), a common ... earlier than Whites/Caucasians or African Americans, according to a ... previous research indicated that Hispanics tend to have more ... published online in the journal Alcoholism: Clinical and Experimental ... pinpoint racial and ethnic disparities in the ages at ...
Breaking Medicine News(10 mins):Health News:Mesothelioma Cancer Research Foundation Broadcasting Symposium Live 2Health News:India Network Announces Pre-existing Condition Health Insurance Coverage for Diabetic Visitors of All Ages Traveling to the United States 2Health News:India Network Announces Pre-existing Condition Health Insurance Coverage for Diabetic Visitors of All Ages Traveling to the United States 3Health News:Friedman Dental Group Announces Their Updated Website 2Health News:Announcing a New TransFold Transition Pack from Pixel Film Studios for Final Cut Pro X Professionals 2Health News:UC Davis Study Finds Hispanics Develop Alcoholic Liver Disease at Younger Ages than Caucasians or African Americans 2
... , WOOSTER, Ohio, Sept. 3 ... of alternative and augmentative communication (AAC) devices for individuals with ... a comprehensive new web resource for speech professionals, teachers, and ... The easy-to-navigate site at www.AACLanguageLab.com ...
... , , SPRINGFIELD, Mass., Sept. 3 ... sales representative to support its growing Taft-Hartley business: , ... ) , , William ... managing director reporting to Scott Buffington, national sales manager ...
... LOS ANGELES, Sept. 3 Saddle Ranch Productions, ... its feature film "Rock and Roll-The Movie" last month, ... documentary entitled "Dietary Supplements, Yes? No? Maybe?" (working title ... investigates America,s fascination and love affair with dietary supplements. ...
... , , SEATTLE, Sept. 3 As ... perform robot-assisted surgery, Swedish Medical Center is home to the ... Swedish established the multidisciplinary robot-assisted surgical program in 2005 and ... any other program in the region. , , ...
... BRANCHVILLE, N.J., Sept. 3 Selective Insurance Group, Inc. (Nasdaq: ... Selective Insurance Company of America ("Selective"): , , ... president, underwriting officer for Mid-Market & Large Accounts. Mr. Barger joined ... president, president Field Operations East for CNA Insurance. , ...
... Radiologic Associates of Fredericksburg (RAF) has added four board-certified ... extensive training covering all medical imaging subspecialties. , ... attributes the practice,s recent growth to a number of factors. ... a growing population while, at the same time, compensating as ...
Cached Medicine News:Health News:PRC Launches New Web Resource for Teaching Language to Children & Adults with Speech Disabilities 2Health News:MassMutual Retirement Services Adds to Taft-Hartley Sales Team 2Health News:MassMutual Retirement Services Adds to Taft-Hartley Sales Team 3Health News:Saddle Ranch Productions Announces New Releases 2Health News:Video: Swedish Medical Center Adds Two New da Vinci Surgical Systems to Support Robot-Assisted Surgical Team 2Health News:Selective Insurance Group Announces Officer Appointments 2Health News:Selective Insurance Group Announces Officer Appointments 3Health News:Radiologic Associates of Fredericksburg Hires Four New Physicians 2
Latex agglutination test for the qualitative and semiquantitative determination of rheumatoid factor in serum....
The SYNCHRON CX3 Delta is a critical care clinical system, providing unparalleled testing speed for the most frequently ordered chemistries-Glucose, BUN, Creatinine, Sodium, Potassium Chloride, CO2 C...
The Rheumatoid Factor (RF) assay is used for the quantitative analysis of rheumatoid factor in human serum....
... choosing a non-contact diagnostic lens, doctors have to ... view and high magnification. Now, with the ... Optical, doctors can have both in one lens. ... view available in a non-contact lens paired with ...
Medicine Products: